Patents Assigned to Streak Laboratories, Inc.
  • Erythrocyte sedimentation rate control
    Patent number: 6331435
    Abstract: A three-phase suspension suitable for use as an erythrocyte sedimentation rate control having the following three components: (1) a synthetic plasma base, (2) a high molecular weight polymer, and (3) mammalian red blood cells. The control is designed to allow the user to monitor the accuracy and precision of analytical methods for determining the sedimentation rate of human erythrocytes in whole blood specimens.
    Type: Grant
    Filed: October 12, 1999
    Date of Patent: December 18, 2001
    Assignees: Streak Laboratories, Inc., Hematronix Inc.
    Inventor: Wayne R. Hengstenberg